Non-GLP Toxicology Studies

After drug discovery, the next stage in the development pipeline involves generating safety data to progress into First-in-Human studies. Non-GLP toxicology studies, which precede GLP studies required for an IND submission, are conducted to assess risks, dosing, and other critical factors essential for in vivo testing.

This flyer presents Pharmaron’s capabilities for efficient generation of robust non-GLP data for assessing the safety of test articles.